8101 - 8110 of 8404 Results
Title
Year
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://europepmc.org/articles/pmc6333467?pdf=renderCitation Count: 164
-
OPENTitle: HCN channelopathy in external globus pallidus neurons in models of Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 85End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.2692Best OA location URL: https://europepmc.org/articles/pmc3058391?pdf=renderCitation Count: 183
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://europepmc.org/articles/pmc3019295?pdf=renderCitation Count: 41
-
OPENTitle: SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 67Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.279Best OA location URL: https://europepmc.org/articles/pmc3010848?pdf=renderCitation Count: 166
-
OPENTitle: Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 570End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22311Best OA location URL: https://europepmc.org/articles/pmc3117674?pdf=renderCitation Count: 404
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
-
OPENTitle: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 686End Page: 687Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.09.007Best OA location URL: https://europepmc.org/articles/pmc4381965?pdf=renderCitation Count: 40
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease2010OPENTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Best OA location URL: https://europepmc.org/articles/pmc3090073?pdf=renderCitation Count: 13
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
RESTRICTEDTitle: PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 52Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3001059Best OA location URL: https://europepmc.org/articles/pmc3129986?pdf=renderCitation Count: 709